ImmunityBio Inc
IBRXLatest QuantConomy context for IBRX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
ImmunityBio Inc
QuantConomy has a structured record for IBRX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- IBRX
- Name
- ImmunityBio Inc
- Coverage
- 3 market/data records
- Sources
- fmp alpaca alphavantage sec nasdaq
Recent signals for IBRX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Jan 15, 12:00 AM | IBRX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-15. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings release | neutral | 40 | Feb 23, 12:00 AM | IBRX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-23. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| other event | neutral | 40 | Jun 10, 09:30 PM | IBRX filed 8-K: Shareholder Vote Results - [weak neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| IBRX | NASDAQ | fmp | ImmunityBio, Inc. |
| IBRX | NASDAQ | alpaca | ImmunityBio, Inc. Common Stock |
| IBRX | NASDAQ | alphavantage | ImmunityBio Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Cohen Cheryl | Insider | exercise | 55,979 | $2.98 | $166,817 | 4 on EDGAR |
| Jul 1, 2026 | Selecky Christobel | Insider | exercise | 35,064 | $2.98 | $104,491 | 4 on EDGAR |
| Jun 29, 2026 | Selecky Christobel | Insider | exercise | 32,173 | $2.98 | $95,876 | 4 on EDGAR |
| Jun 24, 2026 | Simon Barry J. | Insider | sale | 25,000 | $7.88 | $196,908 | 4 on EDGAR |
| Jun 9, 2026 | Wendel Bruce | Insider | grant | 65,600 | — | — | 4 on EDGAR |
| Jun 9, 2026 | Selecky Christobel | Insider | grant | 65,600 | — | — | 4 on EDGAR |
| Jun 9, 2026 | MAXWELL LINDA | Insider | grant | 65,600 | — | — | 4 on EDGAR |
| Jun 9, 2026 | BLASZYK MICHAEL D | Insider | grant | 65,600 | — | — | 4 on EDGAR |
| Jun 9, 2026 | Cohen Cheryl | Insider | grant | 65,600 | — | — | 4 on EDGAR |
| Jun 9, 2026 | Clark Wesley | Insider | grant | 65,600 | — | — | 4 on EDGAR |
| Jun 4, 2026 | Simon Barry J. | Insider | sale | 23,033 | $7.18 | $165,306 | 4 on EDGAR |
| Mar 31, 2026 | SOON-SHIONG PATRICK | See remarks | other | 4,606,596 | $5.43 | $24,999,996 | 4 on EDGAR |
| Feb 24, 2026 | Simon Barry J. | Insider | sale | 75,000 | $12.01 | $900,788 | 4 on EDGAR |
| Feb 23, 2026 | Selecky Christobel | Insider | exercise | 25,000 | $2.98 | $74,500 | 4 on EDGAR |
| Feb 22, 2026 | Adcock Richard | CEO & President | exercise | 152,439 | $0.00 | $0 | 4 on EDGAR |
| Feb 22, 2026 | Sachs David C. | Chief Financial Officer | exercise | 40,650 | $0.00 | $0 | 4 on EDGAR |
| Feb 22, 2026 | LAUER REGAN J | Chief Accounting Officer | exercise | 4,065 | $0.00 | $0 | 4 on EDGAR |
| Feb 22, 2026 | SOON-SHIONG PATRICK | See remarks | exercise | 114,329 | $0.00 | $0 | 4 on EDGAR |
| Feb 20, 2026 | Simon Barry J. | Insider | sale | 10,000 | $9.25 | $92,500 | 4 on EDGAR |
| Feb 10, 2026 | SOON-SHIONG PATRICK | See remarks | exercise | 274,122 | $0.00 | $0 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query IBRX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access